NOC Quantitative Stock Analysis

Validea's guru fundamental report rates Northrop Grumman (NOC) at 77% using its P/B Growth Investor model, based on academic Partha Mohanram's strategy for identifying low book-to-market stocks with sustained growth potential. While the score is just below the 80% threshold for 'interest,' NOC passed most of the model's criteria, with Advertising and R&D to Assets being the only failures, indicating a generally positive fundamental assessment from a growth model known for market outperformance.

Analysis

According to a Validea fundamental report, Northrop Grumman Corp. (NOC) scores a 77% based on the P/B Growth Investor model, a strategy developed by academic Partha Mohanram to identify low book-to-market stocks with sustained growth potential. This score positions NOC just below the 80% threshold that the model uses to indicate interest in a security. The company demonstrates fundamental strength by passing the majority of the model's criteria, including tests for its book-to-market ratio, return on assets (ROA), cash flow generation, and stability in both ROA and sales. However, the analysis also flags specific areas of weakness, as NOC failed the model's screens for Advertising to Assets and Research and Development to Assets. For a growth-oriented assessment, the failure on the R&D metric is particularly notable as it may suggest underinvestment in future innovation relative to the company's asset base within the competitive Aerospace & Defense industry.

Key Decisions for Investors

• Investors should view Northrop Grumman as a fundamentally sound company that narrowly misses the quantitative buy signal from this specific growth model, suggesting a 'hold' or 'monitor' stance may be appropriate.
• The failure on the Research and Development to Assets metric warrants further due diligence, as it could signal a potential risk to long-term innovation and competitive positioning.
• Given the positive performance on core financial health metrics like ROA and cash flow, the report could reinforce confidence for existing long-term holders, while new growth-focused investors might await a stronger catalyst or clarification on R&D spending before initiating a position.